8-KEarnings & ResultsOther EventsExhibits & Filings

QUEST DIAGNOSTICS INC 8-K Report, Financial Results (Jan 25, 2011)

Filed January 25, 2011For Securities:DGX

Summary

Quest Diagnostics Incorporated (DGX) filed an 8-K on January 25, 2011, to report on its financial results for the quarter and year ended December 31, 2010, and a significant new capital allocation decision. The company announced its financial performance for the period, providing investors with key metrics and operational updates for the fiscal year end. In addition to reporting results, the company's Board of Directors authorized a substantial share repurchase program. This authorization allows for the repurchase of up to $750 million of Quest Diagnostics' common stock. This move signals management's confidence in the company's financial health and its commitment to returning value to shareholders.

Key Highlights

  • 1Quest Diagnostics announced its financial results for the fourth quarter and full year ended December 31, 2010.
  • 2The company's Board of Directors authorized a new share repurchase program.
  • 3The authorized share repurchase program is for up to $750 million of the company's common stock.
  • 4The press release detailing the financial results is incorporated by reference.
  • 5The press release detailing the share repurchase authorization is incorporated by reference.
  • 6Robert A. Hagemann, Senior Vice President and Chief Financial Officer, signed the report.

Frequently Asked Questions

This 8-K filing announces that Quest Diagnostics has issued a press release detailing its results for the quarter and year ended December 31, 2010. The specific financial details are available in the referenced press release (Exhibit 99.1).

The authorization of a $750 million share repurchase program indicates that the company's Board of Directors believes the company's stock is undervalued or that management is confident in the company's future cash flows. It demonstrates a commitment to returning capital to shareholders, which can potentially increase earnings per share.

The detailed information is contained within two press releases attached as exhibits to this 8-K filing: Exhibit 99.1 for the financial results and Exhibit 99.2 for the share repurchase authorization. These exhibits are incorporated by reference into the 8-K.